86 related articles for article (PubMed ID: 7244365)
1. Effect of LS 1727, a nitrosocarbamate of 19-nortestosterone, on the R-3327 rat prostatic adenocarcinoma.
Müntzing J; Kirdani RY; Williams PD; Murphy GP
Res Commun Chem Pathol Pharmacol; 1981 May; 32(2):309-16. PubMed ID: 7244365
[TBL] [Abstract][Full Text] [Related]
2. Studies on the mechanism of action of LS 1727, a nitrosocarbamate of 19-nortestosterone.
Hartley-Asp B; Wilkinson R; Venitt S; Harrap KR
Acta Pharmacol Toxicol (Copenh); 1981 Feb; 48(2):129-38. PubMed ID: 6167141
[TBL] [Abstract][Full Text] [Related]
3. Functionality of estrogen receptor and tamoxifen treatment of R3327 Dunning rat prostate adenocarcinoma.
Ip MM; Milholland RJ; Rosen F
Cancer Res; 1980 Jul; 40(7):2188-93. PubMed ID: 7388787
[TBL] [Abstract][Full Text] [Related]
4. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).
George DJ; Dionne CA; Jani J; Angeles T; Murakata C; Lamb J; Isaacs JT
Cancer Res; 1999 May; 59(10):2395-401. PubMed ID: 10344749
[TBL] [Abstract][Full Text] [Related]
5. Human prostatic inhibin suppresses tumor growth and inhibits clonogenic cell survival of a model prostatic adenocarcinoma, the Dunning R3327G rat tumor.
Lokeshwar BL; Hurkadli KS; Sheth AR; Block NL
Cancer Res; 1993 Oct; 53(20):4855-9. PubMed ID: 8402673
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
Pinski J; Reile H; Halmos G; Groot K; Schally AV
Cancer Res; 1994 Jan; 54(1):169-74. PubMed ID: 7903203
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS
Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
[TBL] [Abstract][Full Text] [Related]
8. Novel steroid-linked conjugates of 17 beta-[N-[N'-(2-chloroethyl)-N'-nitroso]carbamoyl]amino acids and their antineoplastic activity against Noble Nb prostate carcinoma model in rats.
Tang W; Schneider MR; Eisenbrand G
Anticancer Drug Des; 1998 Oct; 13(7):815-24. PubMed ID: 9807164
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapeutic and hormonal considerations of the Nb rat prostatic adenocarcinoma model.
Drago JR; Goldman LB; Gershwin ME
Prog Clin Biol Res; 1980; 37():325-63. PubMed ID: 7384092
[No Abstract] [Full Text] [Related]
10. Observations with an S-adenosylmethionine decarboxylase inhibitor in rats with prostatic adenocarcinoma.
Seiler N; Delcros JG; Cipolla B; Chamaillard L; Havouis R; Quemener V; Moulinoux JP
Arzneimittelforschung; 1996 Mar; 46(3):311-5. PubMed ID: 8901156
[TBL] [Abstract][Full Text] [Related]
11. Androgens, androgen receptors, antiandrogens and the treatment of prostate cancer.
Griffiths K; Morton MS; Nicholson RI
Eur Urol; 1997; 32 Suppl 3():24-40. PubMed ID: 9267783
[TBL] [Abstract][Full Text] [Related]
12. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
Brändström A; Westin P; Bergh A; Cajander S; Damber JE
Cancer Res; 1994 Jul; 54(13):3594-601. PubMed ID: 8012987
[TBL] [Abstract][Full Text] [Related]
13. A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model.
Johansson A; Jones J; Pietras K; Kilter S; Skytt A; Rudolfsson SH; Bergh A
Prostate; 2007 Nov; 67(15):1664-76. PubMed ID: 17854058
[TBL] [Abstract][Full Text] [Related]
14. Antitumour activity, toxicity and disposition of LS 1727, a nitroso-chloroethyl carbamate of 19-nortestosterone, in rats and mice.
Gunnarsson PO; Ellman M; Fabiansson E; Gunnarsson K; Jensen G; Müntzing J
Acta Pharmacol Toxicol (Copenh); 1981 Oct; 49(4):290-7. PubMed ID: 7342689
[TBL] [Abstract][Full Text] [Related]
15. Bropirimine as neoadjuvant therapy decreases residual disease and expression of markers PCNA and TGF-beta 1 in a rat orthotopic prostate adenocarcinoma.
Lievano G; Di Domenico D; Brown J; Bridges P; Rubenstein M; Shaw M; Guinan P
Methods Find Exp Clin Pharmacol; 1997 May; 19(4):261-7. PubMed ID: 9228652
[TBL] [Abstract][Full Text] [Related]
16. Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate.
Colombel M; Filleur S; Fournier P; Merle C; Guglielmi J; Courtin A; Degeorges A; Serre CM; Bouvier R; Clézardin P; Cabon F
Cancer Res; 2005 Jan; 65(1):300-8. PubMed ID: 15665307
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.
Xu Y; Dalrymple SL; Becker RE; Denmeade SR; Isaacs JT
Clin Cancer Res; 2006 Jul; 12(13):4072-9. PubMed ID: 16818707
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle-independent death of prostate adenocarcinoma is induced by the trk tyrosine kinase inhibitor CEP-751 (KT6587).
Dionne CA; Camoratto AM; Jani JP; Emerson E; Neff N; Vaught JL; Murakata C; Djakiew D; Lamb J; Bova S; George D; Isaacs JT
Clin Cancer Res; 1998 Aug; 4(8):1887-98. PubMed ID: 9717816
[TBL] [Abstract][Full Text] [Related]
19. Histology, histochemistry, and acid phosphatase of Noble (Nb) rat prostate adenocarcinomas and treatment of an androgen-dependent Nb rat prostate adenocarcinoma.
Drago JR; Goldman LB; Maurer RE; Eckels DD; Gershwin ME
J Natl Cancer Inst; 1980 Apr; 64(4):931-7. PubMed ID: 6929004
[No Abstract] [Full Text] [Related]
20. Effects of LS 1727, a nitrosocarbamate of 19-nortestosterone, on dimethylbenz (a)anthracene-induced mammary tumors in the rat.
Bouveng R; Ellman M; Gunnarsson PO; Jensen G; Liljekvist J; Müntzing J
Eur J Cancer (1965); 1979 Apr; 15(4):407-14. PubMed ID: 108107
[No Abstract] [Full Text] [Related]
[Next] [New Search]
